NCT05369520View on ClinicalTrials.gov

Noninvasive Spinal Cord Stimulation for Recovery of Autonomic Function After Spinal Cord Injury

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2027

Conditions
Spinal Cord InjuriesAutonomic Dysfunction
Interventions
DEVICE

TESCoN device - Thoracic stimulation

TCSCS will be delivered using a non-invasive central nervous system stimulator (TESCoN, SpineX Inc., CA, USA). The stimulation site will be over the thoracic spinal cord (T7-T12, Group 1).

DEVICE

TESCoN device - Lumbosacral stimulation

TCSCS will be delivered using a non-invasive central nervous system stimulator (TESCoN, SpineX Inc., CA, USA). The stimulation site will be over the lumbosacral spinal cord (L1 - L3, Group 2).

Trial Locations (2)

V5Z 1M9

Blusson Spinal Cord Centre, Vancouver

V6Z 1Y6

St Paul's Hospital, Vancouver

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

University of British Columbia

OTHER

NCT05369520 - Noninvasive Spinal Cord Stimulation for Recovery of Autonomic Function After Spinal Cord Injury | Biotech Hunter | Biotech Hunter